Atlanta, GA - Maintaining a lower hematocrit (HCT) can help reduce the risk of cardiovascular death in patients with polycythemia vera, according to the results of CYTO-PV [1]. Those who had an HCT of ...
—A recent study compared outcomes in patients with mantle cell lymphoma who received either autologous or allogeneic hematopoietic stem cell transplantation. Their findings may help in making ...
Nova Biomedical has introduced a portable and user-friendly meter system, called StatStrip Lactate and Hemoglobin/Hematocrit Meter system (StatStrip LAC/Hb/Hct). The system measures Hb, Hct, and LAC ...
—Patients with AML who undergo HCT have variable outcomes, including NRM and relapse. Having tools to predict post-HCT outcomes would help estimate risks and potential survival of individual patients.
A recent study suggests that patients with myelodysplastic syndrome (MDS) could potentially benefit from allogeneic hematopoietic cell transplantation (HCT) regardless of genetic mutation status. This ...